Aprea Therapeutics Inc. Common stock (APRE)

About APRE

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers a…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

8

Website

www.aprea.com/

Fundamentals

1-day range

$0.6005$0.67

Market cap

$7.83M

P/E (trailing)

—

P/E (forward)

-0.82

EPS (trailing)

$-1.54

Dividend yield

—

Beta

-1.22

Avg. volume

100.9K

Forecasts

4 analyst ratings

Aprea Therapeutics Inc. Common stock Competitors

Chosen by industry and closest market cap.

• APRE

  Aprea Therapeutics Inc. Common stock

  $0.8387

  ▼ 2.48%
  Market cap $7.83MP/E —
  $0.548$1.69
• PCSA

  Processa Pharmaceuticals Inc. Common Stock

  $2.07

  ▼ 1.90%
  Market cap $7.65MP/E 3.31
  $1.67$14.24
• CNSP

  CNS Pharmaceuticals Inc. Common Stock

  $5.52

  ▲ 0.11%
  Market cap $7.65MP/E —
  $1.9$10.59
• MTVA

  MetaVia Inc. Common Stock

  $1.71

  ▲ 3.01%
  Market cap $7.49MP/E —
  $0.9661$19.03
• SNGX

  Soligenix Inc. Common Stock

  $0.38

  ▲ 0.00%
  Market cap $8.24MP/E —
  $0.28$3.22
• APUS

  Apimeds Pharmaceuticals US Inc. Common Stock

  $3.87

  ▼ 1.28%
  Market cap $7.29MP/E —
  $3.39$403.1
• XCUR

  Exicure Inc. Common Stock

  $1.34

  ▼ 5.32%
  Market cap $8.60MP/E —
  $1.05$9.48

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Aprea Therapeutics Expands Current Patent Portfolio
  benzinga · 8/28/2026
• Aprea Therapeutics Expands Current Patent Portfolio
  Benzinga · 8/28/2026
• The trading volume of these stocks is deviating from the norm in today's session.
  ChartMill · 8/27/2026
• 12 Health Care Stocks Moving In Thursday's Intraday Session
  Benzinga · 8/27/2026
• Unusual volume stocks in Wednesday's session
  ChartMill · 8/26/2026
• In today's session, these stocks are experiencing unusual volume.
  ChartMill · 8/25/2026
• 12 Health Care Stocks Moving In Monday's Intraday Session
  Benzinga · 8/24/2026
• Wedbush Maintains Outperform on Aprea Therapeutics, Lowers Price Target to $3
  Benzinga · 8/13/2026
• Aprea Therapeutics Q2 EPS $(0.07) Beats $(0.23) Estimate
  Benzinga · 8/12/2026

• Jean-Pierre Bizzari · June 16, 2026 · Grant

  12.6K
• Jean-Pierre Bizzari · June 16, 2026 · Grant

  3.1K
• John B. Henneman III · June 16, 2026 · Grant

  12.6K
• John B. Henneman III · June 16, 2026 · Grant

  3.1K
• John P. Hamill · March 31, 2026 · Buy

  31.0K @ $0.807
• Richard Peters · March 31, 2026 · Buy

  123.9K @ $0.807
• Oren Gilad · March 12, 2026 · Grant

  80.7K
• Oren Gilad · March 12, 2026 · Grant

  20.2K
• John P. Hamill · March 12, 2026 · Grant

  40.4K
• John P. Hamill · March 12, 2026 · Grant

  10.1K

Institutional Ownership

March 31, 2026

Total shares held

2.21M

Total value held

$1.68M

Institutional holders

21